Contribution to the pathogenesis of tumour hypoglycaemia.
D001786:Blood Glucose / Q000378:metabolism; D003981:Diazoxide / Q000627:therapeutic use; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005354:Fibrosarcoma / Q000150:complications* / Q000188:drug therapy; D005943:Gluconeogenesis; D006019:Glycolysis; D006801:Humans; D007003:Hypoglycemia / Q000188:drug therapy / Q000209:etiology*; D007328:Insulin / Q000097:blood; D007773:Lactates / Q000097:blood; D008099:Liver / Q000201:enzymology; D008112:Liver Glycogen / Q000378:metabolism; D008113:Liver Neoplasms / Q000150:complications* / Q000188:drug therapy; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008854:Microscopy, Electron; D008875:Middle Aged; D008930:Mitochondria, Liver; D013268:Stimulation, Chemical
D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D007773:Lactates; D008112:Liver Glycogen; D003981:Diazoxide; D008775:Methylprednisolone